The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
12 05 2021
Historique:
received: 09 10 2020
revised: 19 01 2021
accepted: 31 03 2021
pubmed: 7 4 2021
medline: 24 6 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health threat for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies are a key class of therapeutics that may bridge widespread vaccination campaigns and offer a treatment solution in populations less responsive to vaccination. Here, we report that high-throughput microfluidic screening of antigen-specific B cells led to the identification of LY-CoV555 (also known as bamlanivimab), a potent anti-spike neutralizing antibody from a hospitalized, convalescent patient with coronavirus disease 2019 (COVID-19). Biochemical, structural, and functional characterization of LY-CoV555 revealed high-affinity binding to the receptor-binding domain, angiotensin-converting enzyme 2 binding inhibition, and potent neutralizing activity. A pharmacokinetic study of LY-CoV555 conducted in cynomolgus monkeys demonstrated a mean half-life of 13 days and a clearance of 0.22 ml hour

Identifiants

pubmed: 33820835
pii: scitranslmed.abf1906
doi: 10.1126/scitranslmed.abf1906
pmc: PMC8284311
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Spike Glycoprotein, Coronavirus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI047996
Pays : United States
Organisme : NIAID NIH HHS
ID : F32 AI152296
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : T32 AI007151
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI157155
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI139374
Pays : United States
Organisme : NIAID NIH HHS
ID : UC7 AI094660
Pays : United States
Organisme : NIH HHS
ID : AI157155
Pays : United States
Organisme : NIH HHS
ID : UM1AI48574
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143639
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI148574
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Références

Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Elife. 2018 Mar 07;7:
pubmed: 29513216
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Trends Immunol. 2020 May;41(5):355-359
pubmed: 32249063
J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504
pubmed: 11768292
Biotechnol Prog. 2016 Sep;32(5):1301-1307
pubmed: 27254818
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):519-530
pubmed: 29872003
Antioxid Redox Signal. 2011 Jan 15;14(2):261-73
pubmed: 20524846
Nat Methods. 2019 Nov;16(11):1146-1152
pubmed: 31591575
Science. 2016 Mar 18;351(6279):1343-6
pubmed: 26917592
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11382-8
pubmed: 8876144
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Am Soc Mass Spectrom. 2019 Dec;30(12):2580-2583
pubmed: 31724102
Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Nat Med. 2020 Sep;26(9):1422-1427
pubmed: 32651581
Animal Model Exp Med. 2020 Mar 30;3(1):93-97
pubmed: 32318665
Antimicrob Agents Chemother. 2019 Jul 25;63(8):
pubmed: 31138568
MAbs. 2020 Jan-Dec;12(1):1854149
pubmed: 33319649
Nat Biomed Eng. 2020 Nov;4(11):1030-1043
pubmed: 32747832
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
J Infect Dis. 1997 Nov;176(5):1215-24
pubmed: 9359721
N Engl J Med. 2021 Jan 21;384(3):229-237
pubmed: 33113295
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Biotechnol Prog. 2015 Jan-Feb;31(1):239-47
pubmed: 25403790
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
J Allergy Clin Immunol. 1993 Sep;92(3):457-65
pubmed: 8360397
Nat Med. 2020 May;26(5):640-642
pubmed: 32273610
Nat Methods. 2010 Nov;7(11):901-3
pubmed: 20935651
Cell Host Microbe. 2020 Sep 9;28(3):445-454.e6
pubmed: 32585135
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Bioinformatics. 2020 Feb 1;36(3):765-772
pubmed: 31504163
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
Nature. 2020 Dec;588(7837):327-330
pubmed: 32942285
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Antimicrob Agents Chemother. 2010 Nov;54(11):4534-9
pubmed: 20823290
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Clin Pharmacokinet. 2011 Feb;50(2):131-42
pubmed: 21241072
Cell Rep Med. 2021 Apr 20;2(4):100255
pubmed: 33842902
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
PLoS One. 2015 Dec 30;10(12):e0146021
pubmed: 26717316
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):293-302
pubmed: 21460447
PLoS One. 2020 Sep 11;15(9):e0232311
pubmed: 32915778
Nat Methods. 2011 May 22;8(7):581-6
pubmed: 21602799
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Nat Biotechnol. 2020 May;38(5):540-545
pubmed: 32317764
Nature. 2020 Sep;585(7824):268-272
pubmed: 32396922
Trends Microbiol. 2015 Oct;23(10):653-665
pubmed: 26433697
MAbs. 2011 Jan-Feb;3(1):61-6
pubmed: 20962582
Mol Cell Proteomics. 2019 Dec;18(12):2516-2523
pubmed: 31594786

Auteurs

Bryan E Jones (BE)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA. jones_bryan_edward@lilly.com ester.falconer@abcellera.com.

Patricia L Brown-Augsburger (PL)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Kizzmekia S Corbett (KS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Kathryn Westendorf (K)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Julian Davies (J)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Thomas P Cujec (TP)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Christopher M Wiethoff (CM)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Jamie L Blackbourne (JL)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Beverly A Heinz (BA)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Denisa Foster (D)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Richard E Higgs (RE)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Deepa Balasubramaniam (D)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Lingshu Wang (L)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Yi Zhang (Y)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Eun Sung Yang (ES)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Roza Bidshahri (R)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Lucas Kraft (L)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Yuri Hwang (Y)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Stefanie Žentelis (S)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Kevin R Jepson (KR)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Rodrigo Goya (R)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Maia A Smith (MA)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

David W Collins (DW)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Samuel J Hinshaw (SJ)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Sean A Tycho (SA)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Davide Pellacani (D)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Ping Xiang (P)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Krithika Muthuraman (K)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Solmaz Sobhanifar (S)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Marissa H Piper (MH)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Franz J Triana (FJ)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Jorg Hendle (J)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Anna Pustilnik (A)

Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.

Andrew C Adams (AC)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Shawn J Berens (SJ)

Eli Lilly and Company, Indianapolis, IN 46225, USA.

Ralph S Baric (RS)

University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

David R Martinez (DR)

University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Robert W Cross (RW)

Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Thomas W Geisbert (TW)

Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Viktoriya Borisevich (V)

Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Olubukola Abiona (O)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Hayley M Belli (HM)

Department of Population Health, Division of Biostatistics, New York University Grossman School of Medicine, New York, NY 10016, USA.

Maren de Vries (M)

Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.

Adil Mohamed (A)

Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.

Meike Dittmann (M)

Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.

Marie I Samanovic (MI)

NYU Langone Vaccine Center, Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, NY 10016, USA.

Mark J Mulligan (MJ)

NYU Langone Vaccine Center, Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, NY 10016, USA.

Jory A Goldsmith (JA)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.

Ching-Lin Hsieh (CL)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.

Nicole V Johnson (NV)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.

Daniel Wrapp (D)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.

Jason S McLellan (JS)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.

Bryan C Barnhart (BC)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Barney S Graham (BS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

John R Mascola (JR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Carl L Hansen (CL)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.

Ester Falconer (E)

AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada. jones_bryan_edward@lilly.com ester.falconer@abcellera.com.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH